Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Boehringer Ingelheim
AstraZeneca
Argus Health
UBS
Accenture
Teva
Citi

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021320

« Back to Dashboard

NDA 021320 describes PLENAXIS, which is a drug marketed by Speciality European and is included in one NDA. Additional details are available on the PLENAXIS profile page.

The generic ingredient in PLENAXIS is abarelix. Additional details are available on the abarelix profile page.
Summary for 021320
Tradename:PLENAXIS
Applicant:Speciality European
Ingredient:abarelix
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRAMUSCULARStrength100MG/VIAL
Approval Date:Nov 25, 2003TE:RLD:No

Expired US Patents for NDA 021320

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Speciality European PLENAXIS abarelix INJECTABLE;INTRAMUSCULAR 021320-001 Nov 25, 2003 ➤ Sign Up ➤ Sign Up
Speciality European PLENAXIS abarelix INJECTABLE;INTRAMUSCULAR 021320-001 Nov 25, 2003 ➤ Sign Up ➤ Sign Up
Speciality European PLENAXIS abarelix INJECTABLE;INTRAMUSCULAR 021320-001 Nov 25, 2003 ➤ Sign Up ➤ Sign Up
Speciality European PLENAXIS abarelix INJECTABLE;INTRAMUSCULAR 021320-001 Nov 25, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKesson
Johnson and Johnson
Covington
Deloitte
Chubb
UBS
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.